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DOI: 10.1039/c2an16209aRaman spectroscopy is employed to determine the suitability of the U20S osteoblast-like cell line for
use as a model for human primary osteoblasts, with emphasis on the ability of these cell types to
replicate their tissue of origin. It was found that both cell types demonstrated early stage mineral
deposition that followed significantly different growth patterns. Analysis of the growth pattern and
spectral data from primary cells revealed increasing bone quality ratios and a high crystallinity,
consistent with previous reports. Conversely the investigation of the U20S osteoblast-like cell line
provided evidence of dense multilayered mineralised regions that corresponded more closely to native
bone in terms of its crystallinity and bone quality ratios. This finding contradicts previous reports on
U20S osteoblast-like cells which have consistently described them as non-osteoinductive when cultured
in various conditions on a number of substrates. This work demonstrates the successful application of
Raman spectroscopy combined with biological and multivariate analysis for the investigation of
osteoblast-like U20S cells and human primary osteoblasts, specifically with focus on the osteoinductive
ability of the osteoblast-like cell line and the comparative differences in relation to the primary
osteoblasts.Introduction
When investigating diseases such as cancer, one point of focus is
on the identification of drugs that have a positive influence on
metabolic uptake, cell differentiation and the induction of cell
death. Stem cells are now commonly being used in regenerative
medicine and tissue engineering applications with the primary
aim of replacing or repairing tissue that has been diseased or
damaged.1 The fulfilment of this aim relies heavily on under-
standing cell behaviour and cell interaction with other tissues and
materials both in vitro and in vivo. From this perspective, primary
cells and lineage-specific cells are the gold standard when
studying live cell interactions in vitro. With particular relevance
to bone tissue engineering, de novo bone can be produced by
culturing bone cells onto different biomaterials. Osteoblasts
initiate bone formation by producing osteoid prior to the min-
eralisation process. Osteoid is an unmineralised intracellular
matrix composed of collagen fibrils and fibres combined withaEngineering Research Institute, Nanotechnology and Integrated
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a result, osteoblasts are essential for the process of bone
remodelling and play a crucial role in healing various bone
diseases.2–6 Primary cells are traditionally used when studying
live cell interactions and, in this respect, primary osteoblast cells
isolated directly from the patient are the ideal model when
investigating the formation of new bone. However, their use is
restricted due to the difficulty faced when isolating bone frag-
ments that are capable of producing cells that can be harvested in
sufficient numbers. Primary osteoblasts are also challenging to
expand in vitro and with increasing passage number they can lose
their phenotype in a process known as de-differentiation, leading
to a finite life-span.7–9 More recently, Rubio et al. have reported
the spontaneous transformation of adult stem cells with
increasing passage number, therefore indicating the safety
concerns when expanding cells in large numbers.10
To overcome these limitations, cell lines are often used as an
alternative model for primary cells and, to date, many cell line
models have been chosen because they have a longer life-span
than primary cells. They can also proliferate indefinitely, whilst
maintaining phenotypic stability, therefore overcoming the
limitations of using primary cells. These cell lines are routinely
used to provide an understanding that reflects the interaction of
osteoblasts with various materials,11–14 and are typically obtained
by the immortalization of primary cells through transduction or
retroviral transfection or, in the current study, from cancerousAnalyst
osteosarcoma tissue. However, the use of osteoblast-like cell lines
presents a major potential drawback, which is that the phenotype
expressed may not be a true representation of the phenotype of
primary osteoblasts.15,16
Human osteoblast-like cell lines have been used in bone tissue
engineering as models for investigating primary osteoblast
function and they are used regularly to study growth, integral
expression, cell function and the effects of cytokines and growth
factors. Bilbe et al. reported that three osteoblast-like cell lines
were highly comparable with primary osteoblasts. This finding
was based on the similar expressions of a total of 58 cytokines,
growth factors and bone related proteins from the cell lines and
primary cells.15 Conversely, Clover et al. found that, depending
on the osteoblastic function being investigated, osteoblast-like
cell lines could be used as appropriate models of primary cells.
Osteoblast-like cell lines were concluded to be ideal models for
investigating integrin expression, cell adhesion and the produc-
tion of osteocalcin. However, in terms of alkaline phosphatase
expression and cell proliferation, osteoblast-like cells were not
a good representation of primary cells.16
Various studies have reported the use of osteoblast-like cells
derived from osteosarcoma and have established the relevance of
their use to study in vitro interactions with biomaterials,17–19 bone
cell mineralisation,20,21 and regarding their suitability for a stable
representation of their primary counterparts.7 Using Raman
spectroscopy, similarities in phenotype and biochemical
composition have been found, as well as many differences
between primary cells and the various sarcoma derived cell lines,
including the decrease in the concentration of nucleic acids in
sarcoma derived cells and the increase in protein concentrations
in primary cells.7
Various biological, univariate and multivariate techniques
have been employed in parallel with Raman spectroscopy to
provide a comprehensive comparison of the osteoinductive
potential of human primary osteoblasts (HOBs) and osteoblast-
like U20S cells (U20Ss). This paper determines the suitability of
the U20S osteoblast-like cell line as an alternative to primary
osteoblast cells. It presents spectral data from primary cells
which indicate increasing bone quality ratios and a high crys-
tallinity with culture time. Similarly, there is evidence of a bone
material produced by U20Ss that is comparable to native bone
with respect to its crystallinity and bone quality markers. This in
itself is a very interesting finding, Due to the apparent non-
osteoinductive ability of this cell type.22–24Materials and methods
Primary cell culture
Primary HOBs derived from cancellous bone pieces (Promocell,
UK) were used in this study. Isolation is performed by the
manufacturer. Briefly, cancellous bone was cut into small pieces
that are approximately 2–4 mm in width with appropriate bone
scissors. The pieces were washed and cultivated on a plastic
flask with the manufacturer osteoblast growth medium. After
1–3 weeks, the osteoblasts grow out of the bone pieces and
proliferate. Cells were maintained in osteoblast basal media
(product number C-27001B) and supplemented with osteoblastAnalystsupplement mix (product number C39616) which includes
ascorbic acid and foetal bovine serum.
Osteogenic differentiation was induced by culturing HOBs in
osteoblast mineralisation medium (product number C-27020),
supplemented with osteogenic differentiation medium supple-
ment mix (product number C-39616) which contains ascorbic
acid, beta-glycerophosphate, dexamethasone and foetal bovine
serum. All cells were maintained below 70% confluency and were
passaged every three to four days using 0.05% trypsin-EDTA.
All chemicals were purchased from Promocell, UK. HOBs were
seeded at a density of approximately 30,000 cells per cm2 onto
calcium fluoride (CaF2) substrates (Crystran, UK). Cells were
cultured in normal humidified conditions at 37 C, 5% CO2 for 7,
14, 21 and 28 days, respectively.
Osteoblast-like cell culture
U20S osteoblast-like cells cultivated from the bone tissue of a 15
year old female suffering from a moderately differentiated oste-
osarcoma of the tibia were used in this study (Health Protection
Agency, UK). Cells were maintained in McCoy’s 5A medium
and supplemented with L-Glutamine and 10% foetal bovine
serum (Invitrogen, UK).
Mineralisation was induced by culturing U20Ss in osteoblast
media supplemented with 10 nM dexamethasone, 10 mM beta-
glycerophosphate and 0.05 mM ascorbic acid-2-phosphate
(Invitrogen, UK). All cells were maintained at below 70% con-
fluency and were passaged every three to four days using 0.25%
trypsin-EDTA (Sigma, UK). U20Ss were seeded at a density of
10,000 cells per cm2 onto CaF2 substrates (Crystran, UK). Cells
were cultured in normal humidified conditions at 37 C, 5% CO2
for 7, 14, 21 and 28 days, respectively.
ForRamananalysis, all sampleswere takenat sevenday intervals
and fixed in 10% formalin solution for 10 mins, cells were then
stored in 0.9% sodium chloride (NaCl) for up to 3 weeks.
Alizarin red staining
To confirm the presence of mineralisation, alizarin red staining
was performed at days 7, 14, 21 and 28. Cells were washed three
times in PBS, fixed and permeabilised in 4% paraformaldehyde
(PFA), with 0.1% Triton X-100 for 20 min at room temperature
then washed twice in de-ionised water to remove residual PFA.
Cells were stained with 2% alizarin red for 30 min at room
temperature with gentle shaking. For the colorimetric assay 3.6%
(0.1M) cetylpyridinium chloride was added to each sample for
45 min and the optical density was measured at 405 nm.
Raman spectroscopy
Raman spectra of non-osteogenic and osteogenic cultured HOBs
and U20Ss were obtained at seven day intervals up to 28 days
using A Horiba Jobin-Yvon LabRAM HR800 UV spectrometer
with a singlemodediode laser operating at 660nm.For all spectral
measurements, a x100 water immersion objective (LUMPlanF1,
Olympus, N.A. 1.00W) was employed, providing a spatial reso-
lution of1mmat the sample. The confocal hole was set at 100 mm
for allmeasurements (the specified setting for confocal operation).
The systemwas spectrally calibrated to the 520.7 cm1 spectral line
of Silicon. The LabRAM system is a confocal spectrometer thatThis journal is ª The Royal Society of Chemistry 2012
contains two interchangeable gratings (300 and 900 lines/mm
respectively). In the following experiments the 300 lines/mm
grating was employed, which has a spectral dispersion of
1.5 cm1 per pixel. The detector usedwas a 16-bit dynamic range
Peltier cooled CCD detector. Images of the sample were acquired
using a video camera within the system.
Immunocytochemistry
After 28 days, cells were washed in large volumes of ice-cold PBS
(3  5 min), fixed and permeabilised in 4% PFA containing 0.1%
Triton X-100 for 20 min at 4 C and stained with bone specific
proteins, including, osteocalcin, osteopontin, alkaline phospha-
tase and SPARC (osteonectin) (Santa Cruz Biotechnology Inc,
USA). Following washing, samples were treated with a blocking
solution (PBS containing 1.0% BSA, 5% normal goat serum
(NGS)) for 30 min at room temperature. After blocking, the
samples were washed in PBS and then incubated with the
appropriate primary antibodies for 1 h before exposure to the
opposite secondary antibodies. Following secondary antibody
incubation, cellswere counterstainedwithDAPInucleic acid stain
(Molecular Probes, Inc. Invitrogen). After washing twice in PBS,
substratesweremounted inVector shieldmountingmedia (Vector
Laboratories, UK). The substrates were sealed using a clear nail
varnish and examined using a Carl Zeiss LSM5 Pascal (Carl Zeiss
MicroImaging, Germany) Confocal Laser Scanning Microscope
(CLSM). The diluent for all antibodies was PBS - 1% BSA.
Data pre-processing
It is accepted that spectral artifacts can have a considerable effect
on the interpretation of data. Therefore it is necessary to
distinguish between biochemical information and undesired
effects. With Raman spectroscopy, is it known that before data
interpretation can be performed, pre-processing of data should
be carried out. To this end, Matlab (Mathworks, USA) was used
to routinely pre-process the raw data. In the first instance, band
alignment was performed to correct for instrumental spectral
shifts. As such, all spectra were normalised using the area of the
1449 cm1 band. A CaF2 background spectrum was acquired for
each individual substrate used, and subsequently subtracted
before averaging. A simple baseline subtraction was performed
and smoothing by a 5th order, 11-point Savitzky-Golay filter.
Principal component analysis
Principal component analysis is a multivariate analysis technique
that is widely used to simplify a complex data set of multiple
dimensions. It allows the transformation of different sets of
variables into a smaller set of new variables or principal
components that capture the maximum variance in the data. The
order of the principal components represents their importance to
the original dataset, so the greatest variance is illustrated by the
first principal component (PC1); the second greatest variance is
the second principal component (PC2) and so forth. In principle,
each principal component is a linear combination of the original
variables for the simplified variables, therefore, var (PC1) $ var
(PC2)$ (PCp), where var (PCi) represents the variance of PCi in
the dataset. A scatter plot is generated from the data which
shows groups of points representing variations within theThis journal is ª The Royal Society of Chemistry 2012dataset.25 PCA was performed using Matlab (Mathworks, USA)
following the different data analysis steps described in the
previous section. The other advantage of this method is the
observation of loadings which represent the variance for each
variable (wavenumber) for a given PC. Analysing the loadings of
a PC can give information about the source of the variability
inside a dataset, derived from variations in the molecular
components contributing to the spectra.
This statistical method of analysis was preferred because it is
able to resolve spectral components that are present in different
proportions. This is extremely important when bone is the
material being analysed, as it is heterogeneous in nature, which
results in considerable variations in its spectra.Results and discussion
Cell morphology
HOBs arewidely dispersed cells with a prominent nucleus and they
exhibit a typical elongated fibroblast-like morphology with
a spindle-like appearance (Supplementary Figure 1A–B†). They
have a relatively large body and were measured to be approxi-
mately 130–160 mm in length and 10–20 mm in diameter with an
aspect ratio of 8.3 3.6. The morphology of U20Ss differs and as
such the U20Ss used during this study exhibit typical epithelial
morphological characteristics.After 48 h in culture, therewas little
to no overlap observed and the cells were generally hexagonal in
shapeandofa ‘cobblestone’ appearance that are interconnectedby
cell processes (Supplementary Figure 1C–D†). U20S cells have
a small cell body with a large cell nucleus and few cytoplasmic
processes and were measured to be approximately 30–55 mm in
length and 25–50 mm in diameter with an aspect ratio of 1.2 1.1.
Both non-osteogenic and osteogenic HOBs cell cultures
underwent differing growth patterns, as expected. As can be seen
in Fig. 1, for cells grown in non-osteogenic media (Fig. 1A), there
was no evidence of mineral formation. Non-osteogenic HOBs
maintained a fibroblast-like morphology with a spindle-like
shaped cell body throughout the 28 day culture period. Fig. 1A
shows the control of HOBs samples cultured in non-osteogenic
media, HOBs cultured in osteogenic media for 7 days (Fig. 1B)
highlights a change in growth pattern. When cultured for 7 days
in media with osteogenic supplements, whilst no calcium depo-
sition or mineral formation is observed, there is a dramatic
change in cell morphology. HOBs have not maintained the
elongated fibroblast appearance that is observed in Fig. 1A,
instead they have become more cuboidal in shape and have
formed a dense monolayer during the 7 days in culture. At day
14, HOBs appear more rounded in shape and the monolayer has
become thicker. Cell/protein aggregation within the monolayer is
also observed at this culture time point, as shown in Fig. 1C.
Dramatic changes in cell morphology are observed between days
14–21. Fig. 1C and Fig. 1D show that between these culture
times, the cell monolayer became patchy and in the outer regions
of the cell monolayer, there are discrete areas of calcium depo-
sition and bone nodule formation. By day 28, as shown in Fig. 1E
the outer region of the cell monolayer shows discrete areas of
calcium deposition. There are no bone nodules observed in
Fig. 1E. However, at this time point there were small nodules
present (not shown here).Analyst
Fig. 1 Phase contrast micrographs of HOBs cultured for (A) 28 days in
non-osteogenic media, (B) 7 days, (C), 14 days, (D) 21 days and (E) 28
days in osteogenic media. The scale bar represents 50 mm.Significant differences were observed in the growth pattern of
U20Ss over the 28 day culture period of non-osteogenic and
osteogenic culture. Fig. 2 shows U20Ss cultured for 7 days in (A)
non-osteogenic and (B) osteogenic media. At day 7, theFig. 2 Phase contrast micrographs of U20Ss cultured in non-osteogenic
media for (A) 7 days, (C) 14 days and U20Ss cultured in osteogenic media
for (B) 7 days and (D) 14 days. The scale bar represents 50 mm.
Analystosteogenic U20Ss exhibit no apparent changes in cell
morphology. However, there are areas of calcium deposition
within the matrix, as indicated in Fig. 2B. When Fig. 2A–B is
compared with the day 14 samples Fig. 2 C–D, significant
changes in the growth patterns of both cultures are apparent. The
U20Ss cultured in non-osteogenic media for 14 days appear to
exhibit the typical characteristics of a mineralising culture. This is
due to there being discrete areas of mineral deposition present in
the monolayer, as indicated in Fig. 2C. At day 14 of the U20Ss
cultured in osteogenic media, Fig. 2D, there are large areas of
mineral deposition in the extracellular matrix and also in the
areas surrounding the mineralised regions there is evidence that
U20Ss are actively proliferating. This is due to the U20Ss
maintaining a cell monolayer that surrounds the large mineral
deposits present as shown in Fig. 2D.
Fig. 3 A–F, shows the phase contrast micrographs of U20Ss in
the latter stages of culture in both non-osteogenic (Fig. 3 A, C
and E) and osteogenic media (Fig. 3 B, D and F). In the samples
cultured in non-osteogenic media for 21, 25 and 28 days,
respectively, there is evidence of accelerated mineralisation of the
matrix in large areas of the cell monolayer. At the same time
points, the cells cultured in osteogenic media aggressively
produced bone nodules, which is a trait that is not normally
associated with U20Ss.24 The areas of the mineralised matrix,
observed in Fig. 3 (B, D and F), appear to be substantially more
compact than what is commonly observed with other similar cellFig. 3 Phase contrast micrographs of U20Ss cultured in non-osteogenic
media for (A) 21 days, (C) 25 days, (E) 28 days and U20Ss cultured in
osteogenic media for (B) 21 days, (D) 25 days and (F) 28 days. The scale
bar represents (A–F) 50 mm.
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Fig. 5 Alizarin red staining of U20Ss cultured in osteogenic media for
(A) 7 days, (B) 14 days, (C) 21 days and (D) 28 days. The scale bar
represents (A–D) 50 mm.types, and the areas are interconnected with a dense middle
region and dense elongated bridges that are forming the gaps. In
comparison with Fig. 2D, there is also evidence of active
proliferation of the U20Ss, as indicated by the black arrow.
To quantify the extent of mineralisation of HOBs and U20Ss,
alizarin red staining was performed on both cell types cultured in
both non-osteogenic and osteogenic conditions for 7, 14, 21 and
28 days using phase contrast microscopy. No appreciable
changes were observed in the non-osteogenic cell cultures over
the 28 day culture period. However, this was expected due to the
lack of change in cell morphology over the same culture period.
In work previously published, Gentleman et al. observed nodule
formation from primary osteoblasts which occurred in discrete
patches throughout culture.26 This is reflected in the alizarin
red staining of HOBs after 28 days in culture, as shown in
Fig. 4 A–D. The osteogenic cell cultures underwent a differing
growth pattern over the 28 day culture period, as expected due to
the morphological changes observed. HOBs cultured for up to 28
days in osteogenic media revealed positive staining for calcium
deposition, which increased steadily through each 7 day interval
and at day 28, discrete patches of mineral deposits are evident
(Fig. 4 A–D).
Conversely, throughout the 28 day culture period, the non-
osteogenic U20S samples exhibited a growth pattern that is
typical of that observed during mineralisation (Supplementary
Figure 2 A–D†). Generally, there are small areas present in the
monolayer that show signs of mineralisation of the matrix, which
are indicated by the positive alizarin red staining. The osteogenic
cell culture underwent a similar growth pattern. U20Ss cultured
for up to 28 days in osteogenic media revealed significant positive
alizarin red staining for calcium deposition, which increases
rapidly through each 7 day interval up to day 28 (Fig. 5 A–D). At
this time point, large dense areas of mineral deposits are evident,
as shown in Fig. 5D.
Quantification of alizarin red staining was performed by an
alizarin red colorimetric assay using the cetylpyridinium chlorideFig. 4 Alizarin red staining of HOBs cultured in osteogenic media for
(A) 7 days, (B) 14 days, (C) 21 days and (D) 28 days. The scale bar
represents (A–D) 50 mm.
This journal is ª The Royal Society of Chemistry 2012extraction method. Cells were cultured for the full 28 day culture
period, with samples taken at 7 day intervals. Supplementary
Figure 3 shows the quantification of both non-osteogenic and
osteogenic HOBs and U20Ss cultured for up to 28 days.† An
increase in alizarin red staining of HOBs cultured in non-osteo-
genic media is observed between days 7–14, and in the osteogenic
samples as cell proliferation decreases and differentiation
increases during days 21–28, the alizarin red staining increased
substantially. Supplementary Figure 3 also shows that alizarin
red staining of U20Ss cultured in non-osteogenic media increases
significantly throughout the 28 culture period.† The non-osteo-
genic U20Ss produced a maximum alizarin red staining at day
28, represented by a value of 0.56, and the minimum was at day 7
with a value of 0.15. In comparison to the results obtained for the
non-osteogenic U20Ss, the alizarin red staining of the osteogenic
samples increased as the time in culture increased. The lowest
amount of alizarin red staining was measured at day 7 with
a value of 0.33. A statistical increase was observed at day 28 of
culture with a value of 0.93. Based on the changes observed in the
growth pattern during the 28 day period, it was expected that
alizarin red staining would be significantly higher in the osteo-
genic cultures. However, the non-osteogenic U20Ss had positive
alizarin red staining at higher levels at day 21 that plateaued
between days 21–28. Despite having lower levels of alizarin red
staining at day 28 in non-osteogenic culture, due to the obser-
vations made in cell morphology, these results follow the
expected pattern and highlight that there is extensive minerali-
sation in the U20S cultures.Single cell characterisation of human primary osteoblasts and
U20S osteoblast-like cells
The averaged pre-processed Raman spectra of a single HOB cell
and U20S cell are shown in Fig. 6 (A–B) and are composed of
peaks that are representative of all biomolecules present in cells.
The Raman spectra of both cell types are represented as protein/Analyst
Fig. 6 Raman spectra of (A) HOBs cultured for 48 h in non-osteogenic
media and (B) U20Ss cultured for 48 h in non-osteogenic media.
Fig. 7 Raman spectra of (A) HOBs and (B) U20Ss cultured in osteo-
genic media for 28 days.lipid dominated signatures with prominent protein bands at
1665 cm1 (amide I) and 1248 cm1 (amide III) and strong peaks
that are indicative of lipids at Raman frequencies of 720 cm1
(CN stretching), 985 cm1 and 1319 cm1 (CH bending) and
1448 cm1 (CH deformation). There are also well pronounced
bands that correspond to the O-P-O backbone stretch (788 cm1)
and, specifically in the U20Ss, the peaks at 826 cm1 and
857 cm1, that represent tyrosine ring breathing and O-P-O
asymmetric stretching, dominate the 800–900 cm1 spectral
region. The peaks in the region of 750–900 cm1 are all indicative
of the nucleic acid component of a cell and Fig. 6B shows that, in
U20Ss, the bands in this region are of a higher intensity than
those of HOBs, shown in Fig. 6A.Raman assessment of the osteoinductive potential of human
primary osteoblasts and U20S osteoblast-like cells
After 28 days in culture, dramatic morphological differences
were observed in both cell types. In HOBs there were very
discrete areas of mineralisation and bone nodule formation.
Conversely, in the U20Ss there were large areas of dense min-
eralised structures. These differences are not reflected in the
Raman signal obtained from both cell types, as shown in Fig. 7
(A–B). The time in culture has had little to no effect on theAnalystRaman spectra obtained at this time point. Both cell types
exhibit a Raman signal dominated by peaks that are character-
istic of bone material, namely those found at 960 cm1,
1030 cm1 and 1070 cm1. The HOBs and U20Ss follow the same
trend, showing little fluctuation in the results from 28 days,
except for a slight shift in the phosphate peak, where in the case
of HOBs this peak is at 960.4 cm1 and in U20Ss it is recorded at
962.4 cm1. This indicates a small change in mineral species of the
mineral produced by the HOBs between days 21 and 28.
However, for HOB samples it is evident that there is a decrease in
the CH2 Wag (1445 cm
1) and amide I band (1595–1720 cm1),
which both relate to lipids and proteins respectively.
To confirm the presence of phenotypic markers of osteoblast
cells, immunocytochemistry was performed on both cell types
after 28 days in culture with non-osteogenic and osteogenic
media. Samples were labelled with antibodies to osteopontin
(OPN), osteocalcin (OCN) and alkaline phosphatase (ALP).
Supplementary Figure 4 (A–F) shows localisation of OPN, OCN
and ALP in HOBs cultured for 28 days in (A–C) non-osteogenic
media and (D–F) osteogenic media.† Supplementary
Figure 5 (A–F) shows localisation of OPN, OCN and ALP in
U20Ss cultured in (A–C) non-osteogenic media and (D–F)
osteogenic media for 28 days.† The characterisation of osteo-
genic cells is often achieved by examining the expression of OPN,
OCN and ALP, which can differ with the stage of differentiation.This journal is ª The Royal Society of Chemistry 2012
ALP is usually expressed at higher levels at the earlier stages of
culture; OPN and OCN are both mid to end stage markers of
mineralisation. When comparing Supplementary Figure 4 (A–C)
with (D–F) and Supplementary Figure 5 (A–C) with (D–F), it is
evident that there is a higher degree of positive staining in the
osteogenic samples when compared with the non-osteogenic
samples.† These proteins are found only in bone tissue and, as
such, this indicates that an extracellular matrix has been
produced by the HOBs and U20Ss and over time mineralisation
occurred. In the U20S samples cultured in non-osteogenic media
(Supplementary Figure 5 (A–C)†), there is some evidence of
staining of the bone specific proteins, and this can be correlated
with the cell morphology findings and the alizarin red results.
The osteoinductive ability of the U20S osteoblast-like cell line
described could be a consequence of the addition of osteogenic
supplements in the culture medium. As a result of these condi-
tions, the osteoinductive capability of U20Ss was assessed when
cultured in normal basal culture medium for 28 days. With
regards to U20S osteoblast-like cells, the growth pattern changed
over the 28 day period when cultured in non-osteogenic media.
The cells maintained their cuboidal osteoblast-like morphology,
and there was evidence of calcium deposition in the extracellular
matrix. Therefore Raman measurements were acquired at this
time point, as shown in Fig. 8. At 7, 14, and 21 days of non-
osteogenic culture, the Raman signal was similar to the control
spectra (Fig. 6B). However, at day 28 of non-osteogenic culture,
the Raman spectrum resembles that of the early stages of the
mineralising culture. The spectrum contains peaks that are
characteristic of a proteinaceous extracellular matrix with
Raman bands at 1246–1269 cm1 (amide III) and 1595–
1720 cm1 (amide I). The peaks at 788 cm1, 826 cm1 and
857 cm1 that are indicative of nucleic acids are also prominent in
the spectra. The main interesting feature observed in Fig. 8, is the
addition of the peak (962.9 cm1) that highlights the presence of
a hydroxyapatite bone-like mineral in the sample.
Based on these measurements, it can be argued that the
structures formed by U20Ss are representative of a bone-like
material and that these mineral deposits were produced early in
the culture. This is illustrated by the presence of the PO
symmetric stretch found at 960 cm1, indicative of the inclusionFig. 8 Raman spectra of U20Ss cultured for 28 days in non-osteogenic
media.
This journal is ª The Royal Society of Chemistry 2012of hydroxyapatite in the extracellular matrix. It is note-worthy
that, to the authors’ knowledge, there is little published literature
to suggest that U20S osteoblast-like cells produce mineralised
nodules with such aggressiveness and density. The results
obtained for U20Ss can be compared to another osteosarcoma
derived cell lines, namely SaOS-2. Therefore the production of
mineralised tissue could simply be due to the high proliferation
rate of the U20S cell type.24
Univariate peak analysis
There are many similarities in the Raman spectra obtained from
HOBs and U20Ss at day 28. However small changes in the
frequency and peak position of the peaks that are characteristic
of bone were observed, these were examined using univariate
peak analysis. This was performed at 7, 14, 21 and 28 days, in an
attempt to determine the mineral-to-matrix ratio and carbonate-
to-phosphate ratio of the bone-like material produced by both
cell types and to provide a comparative analysis of these prop-
erties, as shown in Table 1.26–28
In order to calculate the mineral-to-matrix ratio, the intensity
of the PO4
3 phosphate symmetric stretch was used as the metric
of mineral content and the hydroxyproline peak at 850 cm1
was used as a measure of the matrix content.26–28 Carbonate-to-
phosphate ratios were calculated according to the methods
employed by Gentleman et al.26 and Morris et al.,29 based on the
band intensity of the CO3
2 in plane vibrations at 1070 cm1, and
the intensity of the baseline corrected PO4
3 phosphate
symmetric stretch at 960 cm1. Although it has been demon-
strated that the overlap between carbonate n1 and phosphate n3
bands at 1071cm1 makes it difficult to distinguish between
these bands at low carbonate levels (0.3%), at higher carbonate
levels (1–10%), the ratio of the 1071cm1 to 960cm1 peak areas
were seen to be well correlated with the carbonate content.30
Both ratios were calculated from an average of three band
intensities and a global average was obtained.26,31–33
The mineral-to-matrix ratio measures the amount of mineral
in the protein matrix and the carbonate-to-phosphate ratio
measures the substitution of carbonate into the apatite lattice.
The calculated mineral-to-matrix and carbonate-to-phosphate
ratios for primary osteoblasts are shown in Table 1. A linear
trend is observed throughout the full 28 day culture period for
both the mineral-to-matrix and carbonate-to-phosphate ratios.
Hence, as the culture time is increased, the mineral-to-matrix
ratio and carbonate-to-phosphate ratio also increased. From the
univariate analysis, it is demonstrated that the mineral-to-matrixTable 1 Carbonate-to-phosphate ratios and mineral-to-matrix ratios as
determined by univariate analysis carried out by curve fitting Raman
spectra of HOBs and U20Ss cultured for 7–28 days. For each group
spectra were recorded from cells in triplicate. Statistically significant
difference between Sample X and † day 7, ‡ day 14, ₣ day 21 and x day 28
Mineral-to-matrix ratio Carbonate-to-phosphate ratio
HOBs U20Ss HOBs U20Ss
1.01  0.21₣x‡ 1.09  0.91₣x — 1.16  1.02x
7.56  4.79₣x† 2.55  0.05₣ 0.21  0.06₣x 1.81  1.01₣x
14.52  6.24‡† 3.40  0.09x† 0.51  0.34x‡ 2.47  1.91‡
32.39  8.41‡† 4.51  0.18₣‡† 0.67  0.03‡ 3.36  1.80₣‡†
Analyst
and carbonate-to-phosphate ratios for both cell types show
significant differences. In the case of the primary osteoblasts, the
mineral-to-matrix ratio increased with culture time, a trait that
has been associated with the differentiation of stem cells into
osteoblasts27,34 and mineralising calvaria osteoblasts.28,31 The
carbonate-to-phosphate ratios show a ratio at day 7 that
increases significantly through culture time. This highlights that
carbonate substitution begins to occur at the earliest stages of
culture. Further to this, the values reported here are similar to
those calculated for hMSCs34 and they further affirm that
carbonate substitution occurs most rapidly between day 14 and
21. Comparatively, the mineral-to-matrix ratio increased 2 fold
with culture time, and also reached values that are similar to
those reported in previous work.34 This confirms that there is
mineral present in the protein matrix as expected. Based on this,
it can be said that the mineral content of the bone tissue at the
later culture time is higher and that the deposition of mineral into
the apatite lattice occurs most rapidly during days 21 and 28.
The calculated mineral-to-matrix and carbonate-to-phosphate
ratios for U20S osteoblast-like cells are also shown in Table 1.
Notably, while U20Ss follow the same linear pattern of the
carbonate-to-phosphate and mineral-to-matrix ratios observed
for the primary cell line, substantial differences in the calculated
values at the same time points are demonstrated. The carbonate-
to-phosphate ratios increase with culture time and they reach
values that are significantly higher than the primary osteoblasts,
indicating that more carbonate has been substituted into the
apatite lattice. These results are interesting, as the values are
significantly higher than any values reported on the carbonate-
to-phosphate ratios of mineralising cultures. The carbonate-to-
phosphate ratios may not be in accordance with findings repor-
ted by various research groups.26,28,31,34 However, the ratio is
similar to the carbonate-to-phosphate ratio of native bone that
was found to have a value of 3.84  0.03. The mineral-to-matrix
ratios calculated for U20Ss were also significantly different when
compared with the primary osteoblasts. The maximum ratio
after 28 days in culture is 4.51  0.18, whereas the ratio of the
primary osteoblasts at the same time point is 32.4 8.4. This was
not expected after the positive similarity of the carbonate-to-
phosphate ratios to native bone and thus it illustrates that a low
amount of mineral has been deposited in the protein matrix in the
case of the osteoblast-like U20S cells.
Bone quality can be assessed using univariate peak analysis
and in particular, the PO4
3 symmetric band, which is the most
intense Raman peak present in the signal from bone tissue, can
be used to investigate bone crystallinity. A major aspect when
characterising bone material is resolving changes in the phos-
phate band in terms of both frequency and peak position. Bone
mineral crystallinity can be calculated from the full width half
maximum (FWHM) of the PO4
3 symmetric band, whereby the
lower the FWHM the higher the crystallinity of the material.34
The results reported on the primary osteoblast cells used in this
study are consistent with those reported in the literature from
various research groups.26,35,36 This is specifically regarding the
ability of the primary osteoblasts to produce bone nodules in
small mineralised areas in the culture. However, the results
obtained from U20S osteoblast-like cells are interesting to say
the least. This is due to the contradictory findings detailed by
Anderson et al., Raval et al. and Dass et al. who reported thatAnalystosteoblast-like U20Ss have no osteoinductive ability as they
consistently failed to support the formation of mineralised
tissue.22–24 On the contrary, in this study it is demonstrated that
U20Ss do in fact produce mineralised bone tissue, and they do so
very aggressively and in dense multilayered regions of the cell
culture. This is in accordance with studies performed by Hunt
et al.37 who reported that U20Ss expressed higher levels of bone
growth and morphogenic factors than other osteosarcoma cell
lines that are well characterised as being osteoinductive.37
Based on the findings obtained from the univariate peak
analysis, it is suggested that the primary osteoblasts and osteo-
blast-like cells did successfully support the formation of miner-
alised nodules that are significantly different in composition. As
such, the crystallinity of the mineralised nodules is determined
using the FWHM of the PO symmetric stretch at 960 cm1 as
shown in Table 2. Based on this, the primary osteoblasts formed
a highly crystalline bone material with the highest degree of
crystallinity observed at day 14 with a value of 27.11  5.93. An
interesting point is that the crystallinity of the older more mature
bone (day 28) is higher than the newly formed bone (day 21).
This finding could also be due to poorly organised apatite
mineral that occurs during active bone remodelling. The findings
reported here are consistent with those from a study by Farlay
et al. who also found that older bone had a higher crystallinity
that new bone tissue.38 The crystallinity of the bone material
reported here is significantly higher when compared to hMSCs
which are from the same origin.34 This suggests that the primary
osteoblasts produce an apatite mineral that is highly organised,
although less so relative to the crystallinity found in the bone
material produced by U20Ss. The mineral produced by U20Ss is
significantly more crystalline when compared to the primary
osteoblasts. The highest degree of crystallinity of U20Ss is
observed at day 7 with a value of 14.74  1.64. This was not
maintained over longer periods and the crystallinity reached
a plateau between days 14 and 28. Nevertheless, it is suggested
that U20Ss still produced a bone material that was significantly
more crystalline than the bone material produced by primary
osteoblasts. Another key finding, is that the crystallinity of the
U20S bone material can be compared with that of native bone
which was found to have a FWHM of 19.17  5.13.34 The results
may indicate that the U20S osteosarcoma cell line is not a good
model for human osteoblasts, unless one defines a good model as
any cell that makes some apatite-like mineral deposited in/on
collagen, with measured bone quality markers that are similar to
native bone. Nevertheless, U20Ss may have potential to serve as
a model for evaluating and understanding composition differ-
ences between normal bone and osteoblastic lesions sometimes
found when prostate cancer metastasizes to bone.30Principal component analysis
The results obtained from univariate peak analysis highlighted
differences in the composition of the bone material produced
over a 28 day period. Principal component analysis (PCA) was
performed on the Raman spectra obtained from HOBs and
U20Ss cultured in osteogenic media in order to highlight the
similarities and/or differences in the data set.
PCA shows the maximum variance within a data set which is
then represented by a scatter plot. The 3D plot comparing theThis journal is ª The Royal Society of Chemistry 2012
Table 2 Phosphate peak analysis and mineral crystallinity as determined by univariate analysis carried out by curve fitting Raman spectra of HOBs and
U20Ss cultured for 7–28 days in osteogenic media. For each group spectra were recorded from cells in triplicate and n represents the number of spectra
recorded
Phosphate Peak
Frequency (cm1) FWHM (cm1)
HOBs U20Ss HOBs U20Ss
Day 7 (n ¼ 13) — 960.77  0.00 — 14.74  1.64
Day 14 (n ¼ 13) 958.85  3.36 962.86  0.94 27.11  5.93 20.80  2.14
Day 21 (n ¼ 13) 961.59  0.04 962.38  0.07 53.82  1.66 23.55  4.97
Day 28 (n ¼ 13) 960.42  0.82 962.42  0.07 32.14  12.50 22.39  9.45different culture time points for the osteogenic HOBs is displayed
in Fig. 9A. The 3D scores plot shows evidence of significant
separation between the 7 day intervals and subsequently the
scores for these cultures times are compactly clustered. PC1, PC2
and PC3 represent 86%, 8% and 2% of the variance of the data
set, respectively, although group separation appears to be
primarily due to PC2. The loading of PC1 demonstrates the
separation between day 14 and day 28. This loading is predom-
inantly composed of a sharp peak at 960 cm1. MajorFig. 9 (A) Scatter plot of the 3 first principal components after PCA was
carried out on the Raman spectra recorded from HOBs grown in oste-
ogenic media and (B) shows a plot of the loadings that correspond to the
3 first principal components used for Fig. 9 (A).
This journal is ª The Royal Society of Chemistry 2012similarities are observed between the loading of PC1 and the
spectra of bone tissue, specifically in the 900–1000 cm1 spectral
range, highlighting the contribution of the mineral species
present during the recording of the Raman measurements. The
loading of PC2 is a combination of various peaks with different
intensities and it is responsible for discriminating between the
culture period of the day 14 and days 21–28. It accounts for 8%
of the variance of the total data set and the loading plot is
dominated by spectral features that correspond to the lipid and
protein signatures at 1450 cm1 and 1665 cm1, respectively.
From PC2, it can be seen that there is a negative peak at 960 cm1
that represents the phosphate mode and a positive band at
1450 cm1 that relates to the CH2 Wag. PC3 represents only 2%
of the variance, and as such it provides evidence of slight intra-
group variability in day 14 samples, due to the variation in the
mineral species present at that time point.
As highlighted previously, the use of an osteoblast-like cell line
as a model for primary osteoblasts specifically with regards to the
osteoinductive ability is not fully understood. U20Ss were
cultured for a 28 day period in osteogenic media and data pre-
processing was performed, as was the case for the HOBs. The 3D
plot acquired from the U20Ss after PCA and the corresponding
loading plots are displayed in Fig. 10A–B, respectively.
U20Ss demonstrated a different pattern in the 3D scores plot.
The 3D plot shows that the results obtained from the PCA of the
Raman spectra at day 7–14 of culture exhibit few distinguishing
differences between the spectra from the two time points as the
two groups are overlapping. Once again, the measurements
taken at day 21 and day 28 are consistent with those obtained
from the HOBs in that a clear separation is observed at days 21
and 28. PC1 represents 64% of the total variance and this is due
to positive peaks in the areas that represent both proteins and
lipids, including in the 1246–1269 cm1, 1319–1340 cm1,
1445 cm1, 1520–1720 cm1 spectral regions and to the positive
loading at 960 cm1 that corresponds to the phosphate
symmetric stretch. PC2 demonstrates the separation between day
21 and day 28 and PC3 represents the separation between day 21
and the combined groups of days 7, 14 and 28. PC2 accounts for
19% of the explained variance and with regards to the loading
plot it is related to the positive peak representing the mineral
species and the negative peaks corresponding to proteins/lipids.
PC3 represents 6% of the variance and is again related to the
mineral species in the Raman spectra. This indicates that due to
the positive loadings in PC1 that reflect proteins/lipids, PC1
causes separation between days 7–14 from 21–28 and PC2 causesAnalyst
Fig. 10 (A) Scatter plot of the 3 first principal components after PCA
was carried out on the Raman spectra recorded from U20Ss grown in
osteogenic media and (B) shows a plot of the loadings that correspond to
the 3 first principal components used for Fig. 10 (A).separation between days 21–28 due to the positive loading rep-
resenting the mineral species. The loadings of the PCs all contain
a phosphate symmetric stretch at 960 cm1, whilst also contain-
ing peaks in the 1400 cm1 and 1600 cm1 spectral region. The
scores and loadings for U20Ss highlight the significant difference
in the bone mineral formed at days 21 and 28. This further
affirms the differences found in the crystallinity of these time
points. Overall, PCA shows good separation between the bone
mineral formed at the various time points by both cell types.
While PCA does not provide additional analytical information, it
confirms that there are differences in the composition of the bone
material formed by both cell types. Factor analysis was not used
in order to determine the type of mineral formed by both cell
types. However, peak fitting was performed and it is note-worthy
that the type of mineral formed by the primary cells can be
described as a B-type carbonate-substituted apatite and a crys-
talline non-substituted hydroxyapatite, respectively. It was
presumed that a carbonate-substituted apatite would be the main
type of mineral found, in accordance with the high carbonate-to-
phosphates ratios calculated for U20Ss. However, there is
another mineral type produced by U20Ss, which corresponds to
a crystalline non-substituted apatite.28,31,32,34 The types of mineralAnalystfound here are in good agreement with those observed by Stewart
et al., and while all of them are markers and precursors of
hydroxyapatite, the fact that there are different mineral species
indicates the variability of the bone material produced by these
cell types when cultured under the same conditions for the same
period of time.32Conclusion
When considering the use of cell lines and in particular osteo-
sarcoma derived cell lines as an alternative to primary cells, there
are many issues that need to be addressed. On one hand, osteo-
sarcoma derived cells rapidly proliferate and, because they are
immortalized, they maintain their phenotype. On the other hand,
primary osteoblast cells are challenging to culture and with
longer culture times they may become phenotypically unstable.10
However, the major shortcomings of the osteosarcoma cell line
are 1) that it is derived from a bone tumor that is consistently
known to have a very aggressive growth pattern and 2) it may not
be a true representation of human primary cells of the same
origin. In this regard, both cell types produced similar patterns in
their Raman signal, although one significant difference was
observed. Spectral analysis of the osteosarcoma cells showed an
increased concentration of nucleic acids and lower concentration
of proteins in contrast to the human primary osteoblasts which
showed the opposite.
The non-osteoinductive ability of osteosarcoma derived U20Ss
is controversial to say the least and as a consequence it has been
examined and compared with human primary osteoblasts in this
study. In order to do this, various biological, univariate, multi-
variate techniques were employed in parallel with Raman spec-
troscopy to provide a comprehensive comparison of the cell
types.
Primary osteoblasts produced a bone mineral in discrete areas
of the osteogenic culture. This began from day 7 and increased
throughout the 28 day culture period, while all other parameters
remained the same throughout. This cell type is commonly used
to investigate the capability to produce mineralised nodules.
However, in terms of culture methods they are not straight
forward to expand in vitro. U20S osteoblast-like cells, which are
the proposed alternative, also produced a bone material in the
osteogenic culture environment over the 28 day period. U20Ss
also produced mineralised nodules when in a non-osteogenic
environment. The mineralised tissue produced by primary cells is
more commonly compared with native bone, but in this case
while the material is similar to that formed by differentiated
hMSCs,34 based on these findings it can be said that it is less
comparable to native bone. Here it has been shown that the
mineralised structures formed by the osteoblast-like U20Ss has
similar attributes to native bone, i.e. carbonate-to-phosphate
ratio, mineral-to-matrix ratio and crystallinity. This observation
is quite surprising considering not only the origin of these cells
but also the crucial fact that they have been consistently reported
to have no osteoinductive ability. To the best of the author’s
knowledge, this is the first time to date that the bone-like material
produced by U20Ss has been closely analysed by Raman spec-
troscopy and univariate analysis in an attempt to give an overall
understanding using the properties that are commonly employed
to determine bone quality. Although the results may indicate thatThis journal is ª The Royal Society of Chemistry 2012
the U20S osteosarcoma cell is not a good model for human
osteoblasts, they may have potential to serve as a model for
composition differences between normal bone and osteoblastic
lesions.
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